Seres Health, a clinical-stage therapeutics company based in Cambridge, MA in the US has appointed Roger Pomerantz as President and Chief Executive.
Pomerantz has been Chairman of the company since last November.
Seres Health develops products to treat a host of disease conditions based on scientific findings related to the human microbiome.
Pomerantz was most recently Senior Vice President and Worldwide Head of Licensing & Acquisitions at Merck & Co, where he oversaw all licensing and acquisitions at Merck Research Laboratories. Prior to this he was Senior Vice President and Global Franchise Head of Infectious Diseases at Merck.
Before joining Merck, Pomerantz was Global Head of Infectious Diseases at Johnson & Johnson Pharmaceuticals, responsible for all anti-infective agents worldwide. He joined Johnson & Johnson in 2005 as President of Tibotec Pharmaceuticals.
